Design, Implementation, and Evaluation of a Pediatric and Adolescent Type 2 Diabetes Management Program at a Tertiary Pediatric Center
Overview
Affiliations
Global rates of type 2 diabetes in children and adolescents have increased significantly over the past three decades. Type 2 diabetes is a relatively new disease in this age group, and there is a dearth of information about how to structure treatment programs to manage its comorbidities and complications. In this paper, we describe the design and implementation of a personalized multidisciplinary, family-centered, pediatric and adolescent type 2 diabetes program at a tertiary pediatric center in Hamilton, Ontario, Canada. We report the process of designing and implementing such a program, and show that this multidisciplinary program led to improvement in glycated hemoglobin (n=17, 8% at baseline versus 6.4% at 1 year, 95% confidence interval (0.1-0.28), P-value <0.0001) and stabilized body mass index, with lowered C-peptide and no change in fitness or metabolic biomarkers of lipid metabolism and liver function. As type 2 diabetes becomes more prevalent in youth, the need for programs that successfully address the complex nature of this disease is central to its management and to mitigate its long-term adverse outcomes.
Kshatriya M, Wang K, Hildebrand J, Crawford R, Nadarajah A, Youssef M Adolesc Health Med Ther. 2023; 14:175-193.
PMID: 37790916 PMC: 10544169. DOI: 10.2147/AHMT.S405814.
Lake A, Bo A, Hadjiconstantinou M Curr Diab Rep. 2021; 21(12):59.
PMID: 34902067 DOI: 10.1007/s11892-021-01432-1.
Translating knowledge into action to prevent pediatric and adolescent diabesity: a meeting report.
Balakumaran J, Kao Y, Wang K, Ronen G, MacKillop J, Thabane L Adolesc Health Med Ther. 2019; 10:91-101.
PMID: 31692573 PMC: 6716568. DOI: 10.2147/AHMT.S209922.
Fortin M, Chouinard M, Dubois M, Belanger M, Almirall J, Bouhali T CMAJ Open. 2016; 4(4):E588-E598.
PMID: 28018871 PMC: 5173473. DOI: 10.9778/cmajo.20160031.
Zeraatkar D, Nahari A, Wang P, Kearsley E, Falzone N, Xu M Syst Rev. 2016; 5(1):111.
PMID: 27412255 PMC: 4944246. DOI: 10.1186/s13643-016-0288-3.